1. Home
  2. MIST vs CRT Comparison

MIST vs CRT Comparison

Compare MIST & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • CRT
  • Stock Information
  • Founded
  • MIST 2003
  • CRT 1991
  • Country
  • MIST Canada
  • CRT United States
  • Employees
  • MIST N/A
  • CRT N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • CRT Oil & Gas Production
  • Sector
  • MIST Health Care
  • CRT Energy
  • Exchange
  • MIST Nasdaq
  • CRT Nasdaq
  • Market Cap
  • MIST 89.8M
  • CRT 65.1M
  • IPO Year
  • MIST N/A
  • CRT 1992
  • Fundamental
  • Price
  • MIST $2.33
  • CRT $9.78
  • Analyst Decision
  • MIST Strong Buy
  • CRT
  • Analyst Count
  • MIST 2
  • CRT 0
  • Target Price
  • MIST $7.50
  • CRT N/A
  • AVG Volume (30 Days)
  • MIST 640.4K
  • CRT 23.3K
  • Earning Date
  • MIST 08-07-2025
  • CRT 01-01-0001
  • Dividend Yield
  • MIST N/A
  • CRT 9.12%
  • EPS Growth
  • MIST N/A
  • CRT N/A
  • EPS
  • MIST N/A
  • CRT 0.99
  • Revenue
  • MIST N/A
  • CRT $6,834,116.00
  • Revenue This Year
  • MIST N/A
  • CRT N/A
  • Revenue Next Year
  • MIST N/A
  • CRT N/A
  • P/E Ratio
  • MIST N/A
  • CRT $9.77
  • Revenue Growth
  • MIST N/A
  • CRT N/A
  • 52 Week Low
  • MIST $0.63
  • CRT $8.88
  • 52 Week High
  • MIST $2.75
  • CRT $13.31
  • Technical
  • Relative Strength Index (RSI)
  • MIST 78.63
  • CRT 45.32
  • Support Level
  • MIST $1.86
  • CRT $9.64
  • Resistance Level
  • MIST $1.97
  • CRT $9.88
  • Average True Range (ATR)
  • MIST 0.12
  • CRT 0.14
  • MACD
  • MIST 0.04
  • CRT 0.01
  • Stochastic Oscillator
  • MIST 97.12
  • CRT 29.17

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About CRT Cross Timbers Royalty Trust

Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.

Share on Social Networks: